Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 12, 2010, Pages 2771-2779

  Lü, Shuanghong ^a   Li, Ying ^a   Gao, Shaorong ^b   Liu, Sheng ^b   Wang, Haibin ^a   He, Wenjun ^a   Zhou, Jin ^a   Liu, Zhiqiang ^a   Zhang, Ye ^a   Lin, Qiuxia ^a   Duan, Cumi ^a   Yang, Xiangzhong Jerry ^a,c   Wang, Changyong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Embryonic stem cells; Myocardial infarction; Somatic cell nuclear transfer; Tissue engineering

Indexed keywords

ANIMAL; ARTICLE; AUTOTRANSPLANTATION; CELL NUCLEUS TRANSPLANTATION; CYTOLOGY; EMBRYONIC STEM CELL; HEART; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE CELL; METHODOLOGY; MOUSE; PHYSIOLOGY; RAT; REGENERATION; TISSUE ENGINEERING; TISSUE TRANSPLANTATION;

ANIMALS; EMBRYONIC STEM CELLS; HEART; MICE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NUCLEAR TRANSFER TECHNIQUES; RATS; REGENERATION; TISSUE ENGINEERING; TISSUE TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

RATTUS;

EID: 77958540291     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01112.x     Document Type: Article

References (35)

1. Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Failure Rev. 2003; 8: 259-69.
2. Miniati DN, Robbins RC. Heart transplantation: a thirty year perspective. Annu Rev Med. 2002; 53: 189-205.
3. Gardner RS, McDonagh TA. The treatment of chronic heart failure due to left ventricular systolic dysfunction. Clin Med. 2004; 4: 18-22.
4. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005; 115: 572-83.
5. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005; 23: 845-56.
6. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008; 451: 937-42.
7. Lesman A, Habib M, Caspi O, et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng A. 2010; 16: 115-25.
8. Wang H, Zhou J, Liu Z, et al. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. 2010; 14: 1044-55.
9. Zimmermann WH, Didié M, Döker S, et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res. 2006; 71: 419-29.
10. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and antideath strategies. J Mol Cell Cardiol. 2001; 33: 907-21.
11. Muller-Ehmsen J, Whittaker P, Kloner RA, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002; 34: 107-16.
12. Christman KL, - AJ, Fang Q, Sievers RE, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 2004; 44: 654-60.
13. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25: 1015-24.
14. Kofidis T, Lebl DR, Martinez EC, et al. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation. 2005; 112: I173-7.
15. Lu WN, Lü SH, Wang HB, et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng A. 2009; 15: 1437-47.
16. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006; 12: 452-8.
17. Caspi O, Lesman A, Basevitch Y, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res. 2007; 100: 263-72.
18. Guo XM, Zhao YS, Chang HX, et al. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation. 2006; 113:2229-37.
19. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001; 108: 407-14.
20. Laflamme MA, Gold J, Xu CH, et al. Formation of Human Myocardium in the Rat Heart from Human Embryonic Stem Cells. Am J Pathol. 2005; 167: 663-71.
21. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 2003; 107: 2733-40.
22. Kang L, Wang J, Zhang Y, et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009; 5: 135-8.
23. Wakayama T, Tabar V, Rodriguez I, et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science. 2001; 292: 740-3.
24. Byrne JA, Pedersen DA, Clepper LL, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007; 450: 497-502.
25. Koh CJ, Atala A. Therapeutic cloning applications for organ transplantation. Transpl Immunol. 2004; 12: 193-201.
26. Kohda T, Inoue K, Ogonuki N, et al. Variation in gene expression and aberrantly regulated chromosome regions in cloned mice. Biol Reprod. 2005; 73: 1302-11.
27. Brambrink T, Hochedlinger K, Bell G, et al. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc Natl Acad Sci USA. 2006; 103: 933-8.
28. Lü S, Liu S, He W, et al. Bioreactor cultivation enhances NTEB formation and differentiation of NTES cells into cardiomyocytes. Cloning Stem Cells. 2008; 10: 363-70.
29. E LL, Zhao YS, Guo XM, et al. Enrichment of cardiomyocytes derived from mouse embryonic stem cells. J Heart Lung Transplant. 2006; 25: 664-74.
30. Lü SH, Wang HB, Liu H, et al. Reconstruction of engineered uterine tissues containing smooth muscle layer in collagen/Matrigel scaffold in vitro. Tissue Eng A. 2009; 15: 1611-8.
31. Zhao YS, Wang CY, Li DX, et al. Construction of unidirectionally beating 3-dimentional cardiac muscle construct. J Heart Lung Transplant. 2005; 24: 1091-7.
32. Miyahara Y, Nagaya N, Kataoka1 K, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006; 12: 459-65.
33. Zimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002; 90: 223-30.
34. Martinez EC, Kofidis T. Myocardial tissue engineering: the quest for the ideal myocardial substitute. Expert Rev Cardiovasc Ther. 2009; 7: 921-8.
35. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005; 23: 879-84.